ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Organ Systems Working Group Chairs Ask for Set-Aside Funds

December 6, 1985

Breaking With Tradition, NIH Director Heads Obama’s Search for NCI Director.

February 12, 2010

Blochs Plan To Fund National Network Of “Cancer Survivor Parks” In Every City

August 3, 1990

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981